BioNTech SE (BNTX) Net Cash Flow (2018 - 2025)

BioNTech SE has disclosed Net Cash Flow across 8 years of filings, most recently posting -$2.8 billion for Q4 2025.

• Net Cash Flow for Q4 2025 came in at -$2.8 billion, down 2045.25% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.6 billion (down 23.93% YoY), and the FY2025 annual result was -$2.3 billion, down 13.77% from the prior year.
• Net Cash Flow came in at -$2.8 billion for Q4 2025 at BioNTech SE, down from $899.2 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $4.6 billion in Q1 2022 to a low of -$2.9 billion in Q1 2024.
• The 5-year median for Net Cash Flow is $245.8 million (2025), against an average of $418.9 million.
• Across the five-year window, Net Cash Flow surged 61737815.84% in 2021 and plunged 2045.25% in 2025, its largest moves.
• BioNTech SE's Net Cash Flow stood at $342.5 million in 2021, then soared by 175.69% to $944.2 million in 2022, then tumbled by 311.61% to -$2.0 billion in 2023, then jumped by 107.28% to $145.4 million in 2024, then plunged by 2045.25% to -$2.8 billion in 2025.
• The last three Net Cash Flow figures came in at -$2.8 billion (Q4 2025), $899.2 million (Q3 2025), and $150.8 million (Q2 2025), per Business Quant data.